Positioning and Ultrasound Examination of the Gastric Antrum

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Gastric Ultrasound Clinical Trial

Official title:
Effect of Positioning on Ultrasound Examination of the Gastric Antrum

Status Completed

Clinical Trial Summary

The aim of this prospective study was to assess the effect of patient positioning on the ultrasound assessment of gastric contents.

n/a

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04277013` - Ultrasound Assessment of Gastric Content in Fasted Pregnant Women
	Recruiting	`NCT04206111` - Evaluation of Gastric Insufflation Measured by Ultrasound of the Antral Surface During Optiflow Preoxygenation
	Completed	`NCT04738006` - Establishing Gastric Sonography in a Swiss Teaching Hospital
	Recruiting	`NCT04760106` - Learning Curves of Gastric Ultrasound for Novel
	Recruiting	`NCT06003985` - Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists